Precision Biosciences (DTIL) Other financing activities (2018 - 2026)

Precision Biosciences (DTIL) has 9 years of Other financing activities data on file, last reported at $662000.0 in Q1 2026.

• On a quarterly basis, Other financing activities fell 35.79% year-over-year to $662000.0 in Q1 2026; TTM through Mar 2026 was $662000.0, a 35.79% decrease from a year earlier, with the FY2025 full-year figure at $1.0 million, up 13.92% from the prior year.
• Other financing activities for Q1 2026 stood at $662000.0, down from $1.0 million in the prior quarter.
• Over the last five years, Other financing activities for DTIL reached as high as $24.6 million in Q3 2022 and fell as low as $1000.0 in Q4 2023.
• Historically, Other financing activities has averaged $3.5 million across 5 years, with a median of $501000.0 in 2022.
• Across the five-year window, Other financing activities sank 99.03% in 2022 and surged 2916.67% in 2024, its largest moves.
• Year by year, Other financing activities stood at $24.6 million in 2022, then tumbled by 100.0% to $1000.0 in 2023, then surged by 90400.0% to $905000.0 in 2024, then climbed by 13.92% to $1.0 million in 2025, then plunged by 35.79% to $662000.0 in 2026.
• Per Business Quant data, the three most recent Other financing activities figures were $662000.0 in Q1 2026, $1.0 million in Q1 2025, and $905000.0 in Q1 2024.